CONVALESCENT PLASMA THERAPY: A PROMISING APPROACH IN THE TREATMENT OF COVID-19

被引:0
作者
Ahire, Eknath D. [1 ]
Sonawane, Vijayraj N. [2 ]
Surana, Khemchand R. [2 ]
Jadhav, Khanderao R. [1 ]
Sonawane, Deepak D. [1 ]
Shah, Ayaz A. [2 ]
机构
[1] SSSs Divine Coll Pharm, Dept Pharmaceut, Nampur Rd, Nasik 423301, Maharashtra, India
[2] SSSs Divine Coll Pharm, Dept Pharmaceut Chem, Nampur Rd, Nasik 423301, Maharashtra, India
关键词
COVID-19; Convalescent Plasma therapy; Prevention; Monoclonal Antibody; EBOLA-VIRUS DISEASE; ACUTE LUNG INJURY; RESPIRATORY SYNDROME; INFLUENZA PNEUMONIA; MEDIATED-IMMUNITY; ANTIBODY; CORONAVIRUS; SERUM; INFECTION; IMMUNOTHERAPY;
D O I
10.13040/IJPSR.0975-8232.11(9).4078-86
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
At present, the whole world fronting a very challenging situation of the pandemic, severe acute respiratory syndrome due to coronavirus (COVID-19). Today, COVID-19 is spreading rapidly in every part of the world; these pandemic affected billions of people. This virus is found as a new human pathogen. However, currently, there is no hasty therapy available, which will provide fruitful results in this regard. As per previously reported data, human convalescent serum (plasma) will be a great choice for the rescue patients from COVID-19 infection, and it will be readily available if there are adequate numbers of people who have recovered and can donate immunoglobulin consisting serum. It includes the administration of antibodies against a given agent to an affected individual for the cause of treating an infectious disease due to the virus. In disparity, active vaccination involves the induction of an immune response that takes time to develop and varies depending on the vaccine recipient. The plasma therapy has a storied history going back and founds as well reported to treat multiple types of viral diseases. In the current review, we tried to explore and systematically discussed how plasma therapy will create a boon for humans to fight against the novel coronavirus' disease.
引用
收藏
页码:4078 / 4086
页数:9
相关论文
共 74 条
[1]  
Ahire ED, 2020, SYSTEMIC REV PHARM R, P24
[2]  
Alhazzani W, 2020, SURVIVING SEPSIS
[3]  
Alhazzani W, 2020, INTENS CARE MED, V46, P854, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
[4]   Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia [J].
Arabi, Yaseen M. ;
Hajeer, Ali H. ;
Luke, Thomas ;
Raviprakash, Kanakatte ;
Balkhy, Hanan ;
Johani, Sameera ;
Al-Dawood, Abdulaziz ;
Al-Qahtani, Saad ;
Al-Omari, Awad ;
Al-Hameed, Fahad ;
Hayden, Frederick G. ;
Fowler, Robert ;
Bouchama, Abderrezak ;
Shindo, Nahoko ;
Al-Khairy, Khalid ;
Carson, Gail ;
Taha, Yusri ;
Sadat, Musharaf ;
Alahmadi, Mashail .
EMERGING INFECTIOUS DISEASES, 2016, 22 (09) :1554-1561
[5]   Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study [J].
Beigel, John H. ;
Voell, Jocelyn ;
Kumar, Parag ;
Raviprakash, Kanakatte ;
Wu, Hua ;
Jiao, Jin-An ;
Sullivan, Eddie ;
Luke, Thomas ;
Davey, Richard T., Jr. .
LANCET INFECTIOUS DISEASES, 2018, 18 (04) :410-418
[6]   Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill [J].
Benson, Alexander B. ;
Moss, Marc ;
Silliman, Christopher C. .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (04) :431-443
[7]   Convalescent plasma to treat COVID-19 [J].
Bloch, Evan M. .
BLOOD, 2020, 136 (06) :654-655
[8]   Epidemiology and Management of the 2013-16 West African Ebola Outbreak [J].
Boisen, M. L. ;
Hartnett, J. N. ;
Goba, A. ;
Vandi, M. A. ;
Grant, D. S. ;
Schieffelin, J. S. ;
Garry, R. F. ;
Branco, L. M. .
ANNUAL REVIEW OF VIROLOGY, VOL 3, 2016, 3 :147-171
[9]  
Brown C, 2020, INTEGRATING EMERGENC
[10]   Convalescent plasma: possible therapy for novel coronavirus disease 2019 [J].
Cao, Huiling ;
Shi, Yuan .
TRANSFUSION, 2020, 60 (05) :1078-1083